This meta-analysis was conducted to address the following research question: "Among the diagnostic tools CA125, HE-4, ROMA and RMI, which demonstrates the highest accuracy in distinguishing benign from malignant ovarian tumors, and how do these performances vary across menopausal subgroups?". This evidence concerns the gene MUC16 and ovarian cancer.